Navigation Links
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
Date:9/30/2009

carcinogenicity following lifetime exposure to INT131. These results are enabling for INT131 to initiate planned Phase 3 clinical studies.

INT131 is a next-generation insulin sensitizer that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes. INT131 has been designed to provide a safer therapeutic tool for physicians and patients, which is complementary to available classes of medications, and allows for powerful glucose control and the opportunity for modification of the underlying disease. As a SPPARM, INT131 selectively modulates PPAR-gamma, and is ideally positioned to safely improve insulin resistance, addressing an important unmet medical need.

About InteKrin (www.InteKrin.com):

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of high value products by in-licensing clinical-stage therapeutic candidates that address significant unmet medical needs and rapidly move them through critical development stages. InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in nuclear receptors and metabolism, top scientists formerly with the Food and Drug Administration and key clinical and commercialization leaders.

SOURCE InteKrin Therapeutics Inc.


'/>"/>
SOURCE InteKrin Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... ANGELES , March 2, 2015 When someone ... to head to a primary care physician or an ... vast majority of the healthcare provided by doctors and ... system works, but it,s not ideal in every circumstance. ... are actually locations where occupants have higher chances of ...
(Date:3/2/2015)... -- Akron Children,s Hospital has been designated a Diagnostic Imaging ... Radiology (ACR), making it the first hospital in ... in the United States to ... the ACR as a DICOE provides validation that our ... national benchmarks," says Dr. Michael Rubin , chairman, ...
(Date:3/2/2015)... HOUSTON, TX , March 2, 2015 /PRNewswire/ - ... today reported financial results for the first quarter and ... otherwise, are expressed in Canadian dollars and in accordance ... Summary Results ESSA recorded a net ... the three months ended December 31, 2014 (Q1-2015), compared ...
Breaking Medicine Technology:House Call Medicine Helps Patients Receive Treatment While Avoiding the Hassles and Potential Risks of an Urgent Care Facility 2Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative ... tips to bring about self-renewal. A 30 day detox ... first cleaning house. According to Dr. Cutler, expert ... Between environmental toxins like heavy metals, people’s food now ... stress levels, we all have a level of toxic ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 1% for ... will celebrate the addition of over 25 new business members ... Expo West in Anaheim, Calif. 1% for the Planet welcomes ... which will join through its nut butter line. , Food ... and dispose of waste - continues to be a complex ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Market Publishers ... reports worked out by Global Industry Analysts Inc and ... Equipment: Market Research Report . Through 2018, the global ... 6.04% CAGR. The detailed research report suggests a holistic ... radiation therapy equipment as well as covers the top ...
(Date:3/2/2015)... “ Wants and Needs ” was featured on ... the latest and coolest mobile applications on the iOS, ... expert and host of NewsWatch, conducted the app review ... evaluate priorities. , Whether a person needs help re-orienting ... The app allows people to enter and track wants, ...
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
Breaking Medicine News(10 mins):Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:1% For the Planet Members Shine Light on Food as Environmental Issue at Expo West 2Health News:1% For the Planet Members Shine Light on Food as Environmental Issue at Expo West 3Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2
... Ore., May 14 On Sunday, June 29,2008, West ... (ALAO) Reach the Bridge Run, Portland,s most unique 8k ... times, but must reach the,Burnside Bridge by 9:00 a.m. ... Forestry Center, next to the Oregon Zoo and winds ...
... MONTREAL, May 14 /PRNewswire-FirstCall/ - LMS Medical Systems ... the CALM(R) patient,safety software system for obstetrics, today ... saw a substantial rise in revenues over,the previous ... and are,unaudited., Revenue continues to grow substantially ...
... (OTCBB: IVME; Frankfurt: I7VF), INVERNESS, SCOTLAND, May ... for IVMD Inc, the Board is now able,to ... platform and,range of products in development, and is ... the Board,s focus is to seek commercial partners ...
... a One-Stop Resource for Healthcare Professionals, ... of careful research,planning and development, Onward Healthcare, ... nursing jobs and allied health,careers, has launched ... http://www.onwardhealthcare.com . The new site incorporates a ...
... European ,Appetite Controller, Hits U.S. Market, WAYNE, ... gain,control of their appetite and eat up to ... first U.S. dietary supplement that offers the,breakthrough European ... and seven clinical trials demonstrating its,effectiveness, SlimShots is ...
... May 14 The nation,s leading,organization of assisted living ... look to assisted living providers for the model of,care ... CEO and President of the Assisted Living Federation,of America ... on the impact on Americans of the progressive brain ...
Cached Medicine News:Health News:LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record 2Health News:IVMD Inc. kicks off new commercialization initiative 2Health News:IVMD Inc. kicks off new commercialization initiative 3Health News:Onward Healthcare Launches Enhanced Website for Travel Healthcare Professionals 2Health News:New Supplement Helps Americans Eat Less Every Day 2Health News:Assisted Living Industry Looks at Future of Alzheimer's 2
... advanced multi-functional microplate detection system, ,offers ... without compromising flexibility. ,The Ultra ... the Ultra instrument platform. New features ... to the flexibility of the existing ...
... a fully automated microplate based multi-detection ... principles:, , Fluorescence Polarization , ... , High-Performance Luminescence (flash and glow) ... is designed for the widest possible ...
... a flexible multifunction plate reader that offers ... fluorescence intensity, time-resolved fluorescence, high-perfomance luminescence and ... with injectors that deliver reagent at the ... cell assays can be performed easily and ...
... High sensitivity and fast ... eight different radiometric and ... system with true high ... assays, by exploiting the ...
Medicine Products: